Skip to main content
Martha Neagu, MD, Neurology, Boston, MA

MarthaRalucaNeaguMDPhD

Neurology • Boston, MA

Neurooncology

Clinical Fellow in Neurology, Massachusetts General Hospital

Join to view full profile

Dr. Neagu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Neagu's full profile

Already have an account?

Education & Training

  • Brigham and Women's Hospital/Harvard Medical School
    Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Neuro-Oncology, 2014 - 2015
  • Massachusetts General Hospital
    Massachusetts General HospitalFellowship, Neuro-Oncology, 2014 - 2015
  • Harvard University
    Harvard UniversityNo degree, Program in Clinical Effectiveness, 2015
  • Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2011 - 2014
  • Brigham and Women's Hospital
    Brigham and Women's HospitalInternship, Internal Medicine, 2010 - 2011
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 2010
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsPh.D., Cellular, Molecular, and Biophysical Studies, 2009
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsM.Phil., Cellular, Molecular, and Biophysical Studies, 2006
  • Yale University
    Yale UniversityB.S., Molecular, Cellular and Developmental Biology, With distinction, 1999
  • Yale University
    Yale UniversityM.S., Molecular, Cellular and Developmental Biology, 1999

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2018 - 2026
  • MA State Medical License
    MA State Medical License 2013 - 2020
  • American Board of Psychiatry and Neurology Neurology
  • UCNSNeuro-Oncology

Awards, Honors, & Recognition

  • Glasgow-Rubin Achievement Award Columbia University, 2010
  • Helen M. Sciarra Prize in Neurology Columbia University, 2010
  • Alpha Omega Alpha Columbia University, 2009
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy – detecting illusive disease, defining response  
    Huang RY, Neagu MR, Reardon DA and Wen PY, Front. Neurol., 1/1/2015
  • How Treatment Monitoring Is Influencing Treatment Decisions in Glioblastomas  
    Neagu MR, Huang RY, Reardon DA and Wen PY, Current Treatment Options in Neurology, 1/1/2015
  • Lv4 Is a Capsid-Specific Antiviral Activity in Human Blood Cells That Restricts Viruses of the SIVMAC/SIVSM/HIV-2 Lineage Prior to Integration  
    Pizzato M, McCauley SM, Neagu MR, Pertel T, Firrito C, Ziglio, S, Dauphin A, Zufferey M, Berthoux L, Luban J, PLOS Pathogens, 1/1/2015
  • Join now to see all

Books/Book Chapters

  • Clinical Practice: Neurological Complications of Cancer and Its Treatment 
    Chapter: Neurological Complications of Immune-Based Cancer Neurology 
    Neagu MR, Jenkins RW, Reardon DAEditors: David Schiff, MD, Isabel Arrillaga, MD, PhD, Patrick Y. Wen, MD.Edition 3rd,

Abstracts/Posters

  • Defining molecular mechanisms of resistance to Glioblastoma (GBM) immunity using a novel CRISPR/Cas9 in vivo loss-of-function screening platform
    Neagu MR, American Association for Cancer Research; American Academy of Neurology, Washington, DC, 2017; Boston, MA, 2017, 1/1/2017
  • Extracranial Glioma - A Rare Complication of High-Grade Glial Tumors (HGG)
    Neagu MR, American Academy of Neurology, Vancouver, BC, Canada, 1/1/2016
  • In vivo Multiplexed Interrogation of Amplified Genes for Identification of Driver Oncogenes in Ovarian Cancer and Glioblastoma
    Neagu MR, Pediatric Low Grade Astrocytoma Foundation, Boston, MA, 1/1/2014
  • Join now to see all

Lectures

  • Primary Brain Tumors – A clinical Review 
    1/1/2015
  • Functional Genomics Approaches to Solving the GBM Puzzle 
    1/1/2014
  • HIV-1 inhibition by TRIM5-cyclophilin A fusion proteins engineered of human components 
    1/1/2009
  • Join now to see all

Other

  • HIV-1 Inhibition By Human TRIM5-CYP Fusion Proteins (Ph.D. Thesis) 
    Neagu MR, Columbia University
    1/1/2009

Dr. Martha Neagu, Dr. Martha Neagu, MD, Dr. M Neagu, Dr. Martha Raluca Neagu